Shares of Ceapro Inc. (CVE:CZO – Get Free Report) dropped 11.8% during trading on Friday . The stock traded as low as C$0.23 and last traded at C$0.23. Approximately 5,850 shares traded hands during mid-day trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Trading Down 11.8%
The company’s fifty day moving average price is C$0.22 and its two-hundred day moving average price is C$0.23. The company has a current ratio of 7.10, a quick ratio of 18.88 and a debt-to-equity ratio of 8.28. The firm has a market cap of C$688,880.00, a P/E ratio of -2.83 and a beta of 1.38.
About Ceapro
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
See Also
- Five stocks we like better than Ceapro
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Amazon Earnings: 3 Catalysts That Could Drive Shares to $300
- Short Selling – The Pros and Cons
- Why Chipotle Stock May Bounce After a Brutal Sell-Off
- How Investors Can Find the Best Cheap Dividend Stocks
- Why VGT May Be a Smarter Bet Than Chasing Individual Tech Stocks
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
